ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Cassie Edgar

Cassie Edgar

Cassie is a creative connector integrating people, science, and legal solutions to drive business growth.  She is a scientist and an attorney with extensive experience in intellectual property, regulatory, licensing, collaborations and business strategy specifically related to gene editing.

Prior to joining MVS, Cassie was Chief IP & Regulatory Officer for Genus, PLC., a U.K. based genetics company utilizing gene editing technology, and was a board observer for Caribou Biosciences.  Cassie was also at Pioneer DuPont (now Corteva) for 14 years, where she served in research, legal and management roles including IP Counsel, Sr. Regulatory Counsel, and Director in the Agricultural Biotechnology group.

With her direct scientific, IP, regulatory and business leadership experience, Cassie advises clients in product lifecycle management from discovery through post-product launch for gene edited products across both plant and animal applications.

Her areas of focus include intellectual property, regulatory law, licensing, enabling collaborations, and working closely on behalf of clients with regulatory agencies such as the USDA, FDA, and EPA.

Cassie completed Harvard Business School’s General Management Program, adding academic training to the global business perspective she brings having served as in-house counsel for U.S. and U.K. publicly traded companies. She holds a B.S. in Molecular Genetics from The Ohio State University, an M.S. with an emphasis on Biomathematics from North Carolina State University, and obtained her law degree from Drake University.